BlackRock
BBNX

BlackRock’s Beta Bionics BBNX Stock Holding History

BlackRock’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3M Buy
3,340,171
+301,576
+10% +$3.59M ﹤0.01% 2653
2026
Q1 		$30.4M Buy
3,038,595
+124,675
+4% +$1.84M ﹤0.01% 2814
2025
Q4 		$88.8M Buy
2,913,920
+132,589
+5% +$3.54M ﹤0.01% 2178
2025
Q3 		$55.3M Buy
2,781,331
+1,922,972
+224% +$33.8M ﹤0.01% 2443
2025
Q2 		$12.5M Sell
858,359
-568,791
-40% -$8.05M ﹤0.01% 3293
2025
Q1 		$17.5M Buy
+1,427,150
New +$26.6M ﹤0.01% 3015

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

BlackRock's BBNX Position: Q2 2026 in Review

BlackRock increased its Beta Bionics (BBNX) stake by 9.9% in Q2 2026, buying an estimated $3.59M and bringing the position to 3,340,171 shares worth $52.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

BlackRock first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $88.8M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • BlackRock held 3,340,171 shares of Beta Bionics worth $52.3M as of Q2 2026.
  • BlackRock bought 301,576 Beta Bionics shares in Q2 2026, an estimated $3.59M.
  • Beta Bionics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2653 holding.
  • BlackRock first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • BlackRock's Beta Bionics position peaked at $88.8M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.